Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Liquid paraffin oral emulsion
0106030P0AAAAAA
|
Liq paraf (Systemic) | Liquid paraffin | Gastro-Intestinal System | No data available |
|
Lloydspharmacy DiaFix 2mg capsules
0104020L0BQAAAA
|
Lloydspharmacy (Loperamide) | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Lloydspharmacy Heartburn & Indigestion Relief tablets
0103010T0BNABAP
|
Lloydspharmacy (Ranitidine) | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Lloydspharmacy Heartburn and Indigestion liquid aniseed
0101021B0BMAAAH
|
Lloydspharmacy Heartburn Indigestion | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Lloydspharmacy Heartburn and Indigestion liquid peppermint
0101021B0BMABAH
|
Lloydspharmacy Heartburn Indigestion | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Lloydspharmacy Indigestion Relief 75mg tablets
0103010T0BNAAAP
|
Lloydspharmacy (Ranitidine) | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Lloydspharmacy Senna 7.5mg tablets 12 Years Plus
0106020M0BMAAAC
|
Lloydspharmacy (Senna) | Senna | Gastro-Intestinal System | No data available |
|
Lomotil 2.5mg/25microgram tablets (Advanz Phamra)
0104020H0BBAAAA
|
Lomotil | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | No data available |
|
Loperamide 15mg/5ml oral solution
0104020L0AAASAS
|
Loperamide hydrochloride | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Loperamide 2.5mg/5ml oral liquid
0104020L0AAAKAK
|
Loperamide hydrochloride | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Loperamide 4mg/5ml oral liquid
0104020L0AAAHAH
|
Loperamide hydrochloride | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Loritax 2mg capsules
0104020L0BVAAAA
|
Loritax | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Losec I.V. 40mg inj vials
0103050P0BBAHBG
|
Losec | Omeprazole | Gastro-Intestinal System | No data available |
|
Losec Infusion 40mg powder for solution for infusion vials
0103050P0BBAGAV
|
Losec | Omeprazole | Gastro-Intestinal System | No data available |
|
Maalox Plus chewable tablets
0101010L0BEACA0
|
Maalox Plus | Aluminium and magnesium and activated simeticone | Gastro-Intestinal System | No data available |
|
Maalox TC oral suspension
0101010G0BBACAC
|
Maalox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | No data available |
|
Maalox TC tablets
0101010G0BBADAD
|
Maalox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | No data available |
|
Macilax oral powder 13.8g sachets
0106040M0BHAAAA
|
Macilax | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Macilax Paediatric oral powder 6.9g sachets
0106040M0BHABAB
|
Macilax | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Mag-160 capsules
0101010I0BKAAAC
|
Mag-160 | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Mag-500 capsules
0101010I0BLAAAY
|
Mag-500 | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magdose 160mg tablets
0101010I0BFACAL
|
Magdose | Magnesium oxide | Gastro-Intestinal System | No data available |
|
Magdose 400mg tablets
0101010I0BFAFBI
|
Magdose | Magnesium oxide | Gastro-Intestinal System | No data available |
|
MagnaCarb 500mg capsules
0101010F0BDABBE
|
MagnaCarb | Magnesium carbonate | Gastro-Intestinal System | No data available |
|
MagnaOx 160mg capsules
0101010I0BIAAAC
|
MagnaOx | Magnesium oxide | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.